Joe Lonsdale, co-founder of the large government contractor Palantir, wants to embed a team of 15 to 20 “elite engineers” inside the Food and Drug Administration who would “accelerate the FDA’s latest ...

That's far less than today's stock price of about $150. That's what happens when you use actual growth projections to determine a future stock price. Palantir's stock has become unlinked from the ...

Stock volatility is normal for many growth stocks, so it's not to be completely avoided. But if you're buying Palantir right ...

Palantir's valuation hinges on a 44% growth rate and explore its potential as a key player in AI adoption. Read here for more ...

Palantir's stock surge may face challenges with stretched valuation, competition from AI models and pricing pressures. See ...

What astronomers recently discovered about space using supercomputers Simon Pegg Film ‘Angels In The Asylum' Owes Cast, Crew ...

Despite the Trump administration’s efforts to shrink the FDA, Senate appropriators unanimously advanced a funding bill ...

Things on Mars that look like they shouldn't be there FDA issues risk warning for nationwide coffee recall Son of man who was ...

History might be repeating itself as Palantir is objecting to the Defense Intelligence Agency’s plan to award a sole-source contract for custom software development.

Palantir Technologies saw its shares surge to new all-time highs this week. The stock is being fueled by strong AI positioning and geopolitical factors.

Palantir Technologies Inc. is positioning itself as the next Amazon Web Services, according to a senior executive.